Crossmark

The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin

Crossref DOI link: https://doi.org/10.1007/s00535-018-1509-4

Published Online: 2018-09-19

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Furnari, Manuele https://orcid.org/0000-0001-6424-079X
De Alessandri, Alessandra

Cresta, Federico

Haupt, Maria

Bassi, Marta

Calvi, Angela

Haupt, Riccardo

Bodini, Giorgia

Ahmed, Iftikhar

Bagnasco, Francesca

Giannini, Edoardo Giovanni

Casciaro, Rosaria
License Information

Text and Data Mining valid from 2018-09-19
More Information

Article History

Received: 12 June 2018

Accepted: 8 September 2018

First Online: 19 September 2018

Compliance with ethical standards

:

: The authors declare that they have no competing interests.